KDM3A Inhibition Ameliorates Hyperglycemia-Mediated Myocardial Injury by Epigenetic Modulation of Nuclear Factor Kappa-B/P65.
KDM3A Inhibition Ameliorates Hyperglycemia-Mediated Myocardial Injury by Epigenetic Modulation of Nuclear Factor Kappa-B/P65. — المؤلف: Zhang, Bofang — Frontiers in cardiovascular medicine 2022
- المؤلف
- Zhang, Bofang
- النشر
- Frontiers in cardiovascular medicine 2022
- الوصف
- 870999 p.